首页|米非司酮在围绝经期功血患者中的应用及对其性激素水平的影响研究

米非司酮在围绝经期功血患者中的应用及对其性激素水平的影响研究

扫码查看
目的 研究围绝经期功能失调性子宫出血(简称功血)患者使用米非司酮治疗的临床价值.方法 方便选取2023年1-12月福清市妇幼保健院收治的116例围绝经期功血患者为研究对象,根据不同用药方案分为对照组、观察组,每组58例.对照组采用孕激素药物治疗,观察组使用米非司酮药物治疗,治疗周期均为3个月经周期,对比两组的临床效果、性激素水平、子宫内膜厚度与血红蛋白水平、不良反应发生情况.结果 观察组临床治疗总有效率96.55%(56/58)高于对照组的86.21%(50/58),差异有统计学意义(χ2=3.940,P<0.05).治疗3个月经周期后,两组激素水平低于治疗前,且观察组低于对照组,差异均有统计学意义(P均<0.05).治疗3个月经周期后,两组子宫内膜厚度低于治疗前,观察组低于对照组;两组血红蛋白水平高于治疗前,观察组高于对照组,差异有统计学意义(P均<0.05).观察组不良反应总发生率低于对照组,差异均有统计学意义(P<0.05).结论 米非司酮能够治疗围绝经期功血,可以更有效降低性激素水平,改善血红蛋白降低情况,药物不良反应少.
The Application of Mifepristone in Patients with Perimenopausal Dysfunc-tional Uterine Bleeding and Its Impact on Their Sex Hormone Levels
Objective To study the clinical value of mifepristone in the treatment of perimenopausal dysfunctional uterine bleeding.Methods A total of 116 patients with perimenopausal dysfunctional uterine bleeding(referred to as dysfunctional uterine bleeding)admitted to Fuqing Maternal and Child Health Hospital from January 2023 to Decem-ber 2023 were conveniently selected as the research objects.According to different medication regimens,they were di-vided into control group and observation group,with 58 cases in each group.The control group was treated with pro-gesterone drugs,and the observation group was treated with mifepristone drugs.The treatment cycle was 3 menstrual cycles.The clinical effects,sex hormone levels,endometrial thickness and hemoglobin levels,and adverse reactions were compared between the two groups.Results The total effective rate of clinical treatment in the observation group was 96.55%(56/58)higher than that in the control group 86.21%(50/58),and the difference was statistically signifi-cant(χ2=3.940,P<0.05).After 3 menstrual cycles of treatment,the hormone levels of the two groups were lower than those before treatment,and the observation group was lower than the control group,the differences were statistically significant(both P<0.05).After 3 menstrual cycles of treatment,the endometrial thickness of the two groups was lower than that before treatment,and the observation group was lower than that of the control group;the hemoglobin levels of the two groups were higher than those before treatment,and the observation group was higher than the control group,the differences were statistically significant(all P<0.05).The total incidence of adverse reactions in the obser-vation group was lower than that in the control group,the difference was statistically significant(P<0.05).Conclusion Mifepristone can treat perimenopausal dysfunctional uterine bleeding,which can more effectively reduce sex hormone levels,improve hemoglobin reduction,and have fewer adverse drug reactions.

PerimenopausalDysfunctional uterine bleedingMifepristoneSex hormone levelsEndometrial thicknessAdverse reactions

薛思、翁灵、毛丹艳

展开 >

福清市妇幼保健院,福建 福清 350300

围绝经期 功能失调性子宫出血 米非司酮 性激素水平 子宫内膜厚度 不良反应

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(34)